Department of Stomatology, Rizhao People's Hospital, Jining Medical University, Rizhao, P.R. China.
Oncol Res. 2018 May 7;26(4):617-624. doi: 10.3727/096504017X15043589260618. Epub 2017 Sep 6.
Grb2-associated binder 1 (Gab1) is often aberrant in cancerous cells and tissues, whose alteration is responsible for aggressive phenotypes. In this study, we examined the Gab1 expression in human oral squamous cell carcinoma (OSCC) tissues and investigated the cellular and molecular effect of Gab1 on migration, invasion, and cell growth of the OSCC cell lines SCC15 and SCC25. We found that Gab1 was overexpressed in OSCC tissues and cells, which is related to the protein levels of various molecules associated with cellular proliferation, migration, and invasion. Functional assays identified that Gab1 overexpression promoted cell proliferation and invasion of OSCC cells and inhibited cell apoptosis in the SCC15 and SCC25 cell lines. On the other hand, Gab1 silencing affected the proliferation and invasion of OSCC cells and induced cell apoptosis. Western blot assay identified that Gab1 overexpression suppressed the expression of Cdc20 homolog 1 (Cdh1) and then promoted cell invasion in OSCC cells. Furthermore, Gab1-mediated Cdh1 downregulation was significantly reversed when the cells were subjected to an inhibitor of p-Akt. In conclusion, these results suggested that Gab1 induced malignant progression of OSCC cells probably via activation of the Akt/Cdh1 signaling pathway. Thus, Gab1 may be a potential therapeutic target in the treatment of OSCC patients.
Grb2 相关结合蛋白 1(Gab1)在癌细胞和组织中经常发生异常,其改变是导致侵袭性表型的原因。在这项研究中,我们检查了人口腔鳞状细胞癌(OSCC)组织中的 Gab1 表达,并研究了 Gab1 对 OSCC 细胞系 SCC15 和 SCC25 的迁移、侵袭和细胞生长的细胞和分子效应。我们发现 Gab1 在 OSCC 组织和细胞中过度表达,这与与细胞增殖、迁移和侵袭相关的各种分子的蛋白水平有关。功能测定确定 Gab1 过表达促进了 OSCC 细胞的增殖和侵袭,并抑制了 SCC15 和 SCC25 细胞系中的细胞凋亡。另一方面,Gab1 沉默影响了 OSCC 细胞的增殖和侵袭,并诱导了细胞凋亡。Western blot 分析确定 Gab1 过表达抑制了 Cdc20 同源物 1(Cdh1)的表达,从而促进了 OSCC 细胞的侵袭。此外,当细胞受到 Akt 抑制剂处理时,Gab1 介导的 Cdh1 下调显著逆转。总之,这些结果表明 Gab1 通过激活 Akt/Cdh1 信号通路诱导 OSCC 细胞的恶性进展。因此,Gab1 可能是治疗 OSCC 患者的潜在治疗靶点。